Ramiven 100mg Tablet is an anticancer medication containing the active ingredient Abemaciclib.
It is used to treat certain types of breast cancer (hormone receptor-positive, HER2 negative breast cancer) that are advanced or metastatic.
It can also be used to treat advanced or metastatic non-small cell lung cancer, advanced or metastatic endometrial cancer, and pediatric patients with neuroblastoma.
Uses:
Advanced or metastatic breast cancer.
Advanced or metastatic non-small cell lung cancer.
Advanced or metastatic endometrial cancer.
Pediatric patients with neuroblastoma.
Therapeutic Effects:
Ramiven 100mg Tablet works by blocking the activity of CDK4 and CDK6 enzymes, which are involved in cell division and growth.
By inhibiting these enzymes, it slows down or stops the growth of cancer cells.
Interaction with Other Drugs:
Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products.
Certain medications may interact with Ramiven 100mg Tablet and reduce effectiveness by causing undesirable side effects.
Safety Advices:
Pregnancy: Ramiven 100mg Tablet is unsafe for pregnant women as it may cause foetal harm.
Breast Feeding: Ramiven 100mg Tablet is not recommended during breastfeeding, as it is excreted in human milk.
Lungs: Inform your doctor if you have any lung diseases before starting the treatment.
Liver: Regular monitoring of liver function tests is recommended.
Alcohol: It is generally recommended that patients taking Ramiven 100 mg Tablet should avoid or limit their alcohol intake.
Driving: Ramiven 100mg Tablet may cause side effects such as fatigue, dizziness, or blurred vision that can impair a patient's ability to drive or operate machinery safely.
Ramiven 100mg Tablet is usually taken orally, with or without food.
The tablets should be swallowed whole with a glass of water and not crushed, chewed or broken.
The dosage and frequency will depend on various factors, including the patient's age, weight, overall health, and the type and stage of cancer being treated.
It is important to follow the dosing instructions provided by a healthcare provider, and not to adjust the dosage or frequency without consulting with them first.
FAQs:
What is Ramiven 100mg Tablet used for?
Ramiven 100mg is used to treat certain types of cancer, including advanced or metastatic breast cancer, advanced or metastatic non-small cell lung cancer, advanced or metastatic hormone receptor-positive, HER2-negative endometrial cancer, and high-risk neuroblastoma in pediatric patients.
How should Ramiven 100mg Tablet be taken?
Ramiven 100mg Tablet is typically taken orally, with or without food, as prescribed by a healthcare provider. The tablets should be swallowed whole with a glass of water and not crushed, chewed or broken.
What are the potential side effects of Ramiven 100mg Tablet?
Common side effects of Ramiven 100mg may include diarrhea, nausea, vomiting, fatigue, decreased appetite, abdominal pain, headache, and low white blood cell count. Less common but more serious side effects may include liver problems, blood clots, and pulmonary embolism.
Can Ramiven 100mg Tablet be taken during pregnancy?
Ramiven 100mg Tablet should not be used during pregnancy unless necessary and the potential benefits outweigh the potential risks to the fetus. Women of childbearing age should use effective contraception while taking it and for at least three weeks after the last dose.
How long will I need to take Ramiven 100 mg Tablet?
The length of treatment with Ramiven 100mg Tablet will depend on a variety of factors, including the type and stage of cancer being treated, how well the medication is tolerated, and the patient's response to treatment.
Can Ramiven 100mg Tablet be taken with other medications?
Ramiven 100mg Tablet may interact with other medications, so it's important to inform your healthcare provider about all medications, supplements, and herbal products you are taking.
Fact Box:
Molecule name: Abemaciclib.
Therapeutic class: Anticancer.
Pharmacological class: Alkylating agents.
Indications:
Advanced or metastatic breast cancer.
Advanced or metastatic non-small cell lung cancer.
